Concepedia

L. Albiges

LA

2

Publications

31

Citations

2

H-Index

2022

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Institut Gustave Roussy

Institut de Cancérologie Strasbourg

L. Albiges is an author at Vall d'Hebron Hospital Universitari specializing in oncology, urology, and medicine.

Top concepts

Publications per year

2022–2024

2

Publications

2

LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial

Lars Bergmann, Marit Ahrens, L. Albiges et al. · Annals of Oncology · 2024 · 18 citations · Full text

, , +7

1448O Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)

L. Albiges, H.P. Gurney, V. Atduev et al. · Annals of Oncology · 2022 · 13 citations

, , +6

Rows per page

1–2 of 2